1125 related articles for article (PubMed ID: 22435913)
1. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
[TBL] [Abstract][Full Text] [Related]
2. Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.
Li J; Liang J; Zhao T; Lin Y
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1034-9. PubMed ID: 26780618
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
Choi EK; Chong A; Ha JM; Jung CK; O JH; Kim SH
Clin Endocrinol (Oxf); 2017 Jul; 87(1):73-79. PubMed ID: 28329426
[TBL] [Abstract][Full Text] [Related]
4. Treatment with sorafenib in advanced thyroid cancer - a case report.
Krajewska J; Olczyk T; Roskosz J; Paliczk-Cieślik E; Smietana AK; Kaczmarek-Borowska B; Jarząb B
Endokrynol Pol; 2010; 61(5):492-6. PubMed ID: 21049464
[TBL] [Abstract][Full Text] [Related]
5. PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
Davidson M; Olsen RJ; Ewton AA; Robbins RJ
Endocr Pract; 2017 Dec; 23(12):1425-1429. PubMed ID: 29144798
[TBL] [Abstract][Full Text] [Related]
6. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
[TBL] [Abstract][Full Text] [Related]
7. Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Iyer P; Mayer JL; Ewig JM
Thyroid; 2014 Jan; 24(1):169-74. PubMed ID: 23544852
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma metastatic to the pancreas: Case report.
Cho M; Acosta-Gonzalez G; Brandler TC; Basu A; Wei XJ; Simms A
Diagn Cytopathol; 2019 Mar; 47(3):214-217. PubMed ID: 30479026
[TBL] [Abstract][Full Text] [Related]
9. Multiple Simultaneous Rare Distant Metastases as the Initial Presentation of Papillary Thyroid Carcinoma: A Case Report.
Yang J; Ma Y; Gong Y; Gong R; Li Z; Zhu J
Front Endocrinol (Lausanne); 2019; 10():759. PubMed ID: 31781034
[TBL] [Abstract][Full Text] [Related]
10. Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Danilovic DLS; Castro G; Roitberg FSR; Vanderlei FAB; Bonani FA; Freitas RMC; Coura-Filho GB; Camargo RY; Kulcsar MA; Marui S; Hoff AO
Arch Endocrinol Metab; 2018 Jun; 62(3):370-375. PubMed ID: 29791660
[TBL] [Abstract][Full Text] [Related]
11. Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
Yang J; Gong R; Ma Y; Gao J; Li Z; Zhu J; Gong Y
Front Endocrinol (Lausanne); 2021; 12():654638. PubMed ID: 33897621
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the novel BRAF complex mutation, BRAF(V600delinsYM) , identified in papillary thyroid carcinoma.
Matsuse M; Mitsutake N; Tanimura S; Ogi T; Nishihara E; Hirokawa M; Fuziwara CS; Saenko VA; Suzuki K; Miyauchi A; Yamashita S
Int J Cancer; 2013 Feb; 132(3):738-43. PubMed ID: 22752848
[TBL] [Abstract][Full Text] [Related]
13. THE RELATIONSHIP OF BRAF
Santhanam P; Khthir R; Solnes LB; Ladenson PW
Endocr Pract; 2018 Jan; 24(1):21-26. PubMed ID: 29144823
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.
Murakami Y; Shimura T; Okada R; Kofunato Y; Ishigame T; Yashima R; Nakano K; Suzuki S; Takenoshita S
Clin J Gastroenterol; 2018 Dec; 11(6):521-529. PubMed ID: 29948817
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic metastasis from papillary thyroid carcinoma: Case report and literature review.
Stein R; Harmon TS; Harmon CE; Kuo E; Ozdemir S
Hell J Nucl Med; 2021; 24(2):140-148. PubMed ID: 34352049
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E mutation associated with non-radioiodine-avid status in distant metastatic papillary thyroid carcinoma.
Yang K; Wang H; Liang Z; Liang J; Li F; Lin Y
Clin Nucl Med; 2014 Aug; 39(8):675-9. PubMed ID: 24978326
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between
Chang JW; Park KW; Heo JH; Jung SN; Liu L; Kim SM; Kwon IS; Koo BS
World J Surg; 2018 Jan; 42(1):114-122. PubMed ID: 28808756
[TBL] [Abstract][Full Text] [Related]
18. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
19. Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).
Nucera C; Goldfarb M; Hodin R; Parangi S
Biochim Biophys Acta; 2009 Apr; 1795(2):152-61. PubMed ID: 19356676
[TBL] [Abstract][Full Text] [Related]
20. The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma.
Pelizzo MR; Dobrinja C; Casal Ide E; Zane M; Lora O; Toniato A; Mian C; Barollo S; Izuzquiza M; Guerrini J; De Manzini N; Merante Boschin I; Rubello D
Biomed Pharmacother; 2014 May; 68(4):413-7. PubMed ID: 24721322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
